Oct 29 (Reuters) - SURTECO GROUP SE SURG.DE :
* SALES AND EBIT SIGNIFICANTLY INCREASED IN THE FIRST THREE
QUARTERS
* 9M EBIT ROSE 105 PERCENT TO 59.1 MILLION EUR
* 9M SALES ROSE 23 PERCENT TO 566.1 MILLION EUR
* NOW EXPECTING SALES BETWEEN EUR 725 AND EUR 750 MILLION
(ORIGINAL TARGET RANGE: EUR 650 TO EUR 675 MILLION) AND AN EBIT
BETWEEN EUR 63 AND EUR 68 MILLION (ORIGINAL TARGET RANGE: EUR 47
TO EUR 52 MILLION) FOR FULL YEAR 2021.
* 9-MONTH CONSOLIDATED NET PROFIT WENT UP BY 112 % TO EUR
39.4
MILLION (2020: EUR 18.6 MILLION).
Source text for Eikon: ID:nEQ6ZJ7R2a
Further company coverage: SURG.DE
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))